Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting epigenetic machinery: Emerging novel allosteric inhibitors
Fei Ye, Jing Huang, Hongbo Wang, et al.
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107406-107406
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 163
Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases
Shuaifei Ji, Mingchen Xiong, Huating Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 63
Along the allostery stream: Recent advances in computational methods for allosteric drug discovery
Duan Ni, Zong‐Tao Chai, Ying Wang, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 12, Iss. 4
Closed Access | Times Cited: 51
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site
Zhiqing Liu, Yi Li, Haiying Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2388-2408
Open Access | Times Cited: 38
Epigenetic Regulation of Macrophage Polarization in Cardiovascular Diseases
Sumra Komal, Shengna Han, Liu-Gen Cui, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 141-141
Open Access | Times Cited: 18
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 18
Drug design targeting active posttranslational modification protein isoforms
Fanwang Meng, Zhongjie Liang, Kehao Zhao, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1701-1750
Closed Access | Times Cited: 43
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Yi Zhang, Deqin Rong, Bingbing Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7900-7925
Closed Access | Times Cited: 37
Epigenetic Regulation of Fungal Secondary Metabolism
Yufei Zhang, Wenbin Yu, Yi Lü, et al.
Journal of Fungi (2024) Vol. 10, Iss. 9, pp. 648-648
Open Access | Times Cited: 5
The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling
Fabienne Gally, Sarah K. Sasse, Jonathan S. Kurche, et al.
JCI Insight (2020) Vol. 6, Iss. 2
Open Access | Times Cited: 29
Fusarium BP1 is a reader of H3K27 methylation
Guangfei Tang, Jianlong Yuan, Jing Wang, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 18, pp. 10448-10464
Open Access | Times Cited: 25
Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics
Wensi Zhao, Kai-Feng Chen, Man Liu, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 8, pp. 1701-1711
Open Access | Times Cited: 9
DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine‐5 methylation
Dongxing Shao, Cihang Liu, Y. Wang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 12
Open Access | Times Cited: 8
Both intra and inter-domain interactions define the intrinsic dynamics and allosteric mechanism in DNMT1s
Zhongjie Liang, Yu Zhu, Jie Long, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 749-764
Open Access | Times Cited: 23
Recent progress on small molecules targeting epigenetic complexes
Yukihiro Itoh, Yuri Takada, Yasunobu Yamashita, et al.
Current Opinion in Chemical Biology (2022) Vol. 67, pp. 102130-102130
Closed Access | Times Cited: 13
Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs
Yuan Zhao, Yuanyuan Guan, Fang Zhao, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114144-114144
Closed Access | Times Cited: 11
First-in-Class Allosteric Inhibitors of DNMT3A Disrupt Protein–Protein Interactions and Induce Acute Myeloid Leukemia Cell Differentiation
Jonathan E. Sandoval, Raghav Ramabadran, Nathaniel J. Stillson, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10554-10566
Closed Access | Times Cited: 11
Sophora subprosrate polysaccharide suppress the inflammatory reaction of RAW264.7 cells infected with PCV2 via regulation NF-κB/MAPKs/c-Jun signal pathway and histone acetylation modification
Jian Yang, Mixia Cao, Wen-Yue HU, et al.
International Journal of Biological Macromolecules (2020) Vol. 159, pp. 957-965
Closed Access | Times Cited: 11
Insights into Conformational Dynamics and Allostery in DNMT1-H3Ub/USP7 Interactions
Yu Zhu, Fei Ye, Ziyun Zhou, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5153-5153
Open Access | Times Cited: 9
Role of protein-protein interactions in allosteric drug design for DNA methyltransferases
Zhongjie Liang, Yu Zhu, Xingyi Liu, et al.
Advances in protein chemistry and structural biology (2020), pp. 49-84
Closed Access | Times Cited: 9
Mutations in Epigenetic Regulation Genes in Gastric Cancer
М. В. Немцова, Alexey I. Kalinkin, Ekaterina Kuznetsova, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4586-4586
Open Access | Times Cited: 8
Mechanistic insights into allosteric regulation of methylated DNA and histone H3 recognition by SRA and SET domains of SUVH5 and the basis for di‐methylation of lysine residue
Suman Abhishek, Waghela Deeksha, Eerappa Rajakumara
FEBS Journal (2022) Vol. 290, Iss. 4, pp. 1060-1077
Closed Access | Times Cited: 6
Deciphering Divergent Trypanosomatid Nuclear Complexes by Analyzing Interactomic Datasets with AlphaFold2 and Genetic Approaches
Elvio Rodríguez Araya, Marcelo L. Merli, Pamela Cribb, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 6, pp. 1267-1282
Open Access | Times Cited: 3
Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
Oriol de Barrios, Maribel Parra
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3127-3127
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top